BJDXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States...

Stats
本日の出来高	571 313
平均出来高	48 417.00
時価総額	1.73M
EPS	$0 ( 2024-03-25 )
次の収益日	( $-0.720 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0700
ATR14	$0.0150 (2.34%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Dey Svetlana	Buy	500	Common Stock
2023-12-13	Dey Indranil	Buy	500	Common Stock
2023-09-26	Scally Frances P	Buy	0
2023-03-24	Dey Svetlana	Buy	10 000	Common Stock
2023-03-28	Dey Indranil	Buy	2 000	Common Stock

INSIDER POWER
43.51
Last 55 transactions
Buy: 889 772 \| Sell: 456 992

Bluejay Diagnostics, Inc. 相関

10 最も正の相関
BPYPP	0.971
ISTR	0.97
ADES	0.968
SFBS	0.968
FFWM	0.966
SGMO	0.965
NUWE	0.965
FSEA	0.964
ARVL	0.964
IMBI	0.962

10 最も負の相関
MSDA	-0.972
BRIVU	-0.97
VLAT	-0.964
ADAL	-0.962
TIOAU	-0.961
TIOA	-0.96
PPYAU	-0.956
ZING	-0.956
NVCN	-0.953
BRIV	-0.952

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bluejay Diagnostics, Inc. 財務諸表

Annual	2023
収益:	$0
総利益:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2023
収益:	$0
総利益:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2022
収益:	$249 040
総利益:	$48 911.00 (19.64 %)
EPS:	$-9.15

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.275

Financial Reports:

No articles found.

Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.